TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. MRNA
3. MRK
4. BILL
5. EL
6. RARE
7. LOW
8. DE
9. LYTS
10. UBER

Go back to TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
TG THERAP (NASDAQ: TGTX) Delayed: 51.69 --0 (-0%)
Previous Close $51.69    52 Week High $14.87 
Open $51.69    52 Week Low $4.90 
Day High $51.69    P/E N/A 
Day Low $51.69    EPS $-0.67 
Volume 150